Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Santosh Valvi

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cancers|October 15, 2020
A Novel Orthotopic Patient-Derived Xenograft Model of Radiation-Induced Glioma Following MedulloblastomaJacqueline P Whitehouse, Meegan Howlett, Hilary Hii, et al.
Neuro-Oncology|February 12, 2025
High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeuticDannielle H Upton, Jie Liu, Sandra M George, et al.
Neuro-Oncology|June 11, 2025
Novel GABAAR antagonists target networked gene hubs at the leading-edge in high-grade gliomasChloe Shard, Anya C Jones, Anahita Fouladzadeh, et al.
Frontiers in Oncology|May 1, 2023
BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experienceSarah M Trinder, Campbell McKay, Phoebe Power, et al.
Nature Communications|May 19, 2026
Precision-guided therapy in H3K27-altered diffuse midline gliomaCampbell J L McKay, Chelsea Mayoh, Phoebe Power, et al.
The Journal of Clinical Investigation|February 6, 2024
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine gliomaRyan J Duchatel, Evangeline R Jackson, Sarah G Parackal, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancers|October 15, 2020
A Novel Orthotopic Patient-Derived Xenograft Model of Radiation-Induced Glioma Following MedulloblastomaJacqueline P Whitehouse, Meegan Howlett, Hilary Hii, et al.
Neuro-Oncology|February 12, 2025
High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeuticDannielle H Upton, Jie Liu, Sandra M George, et al.
Neuro-Oncology|June 11, 2025
Novel GABAAR antagonists target networked gene hubs at the leading-edge in high-grade gliomasChloe Shard, Anya C Jones, Anahita Fouladzadeh, et al.
Frontiers in Oncology|May 1, 2023
BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experienceSarah M Trinder, Campbell McKay, Phoebe Power, et al.
Nature Communications|May 19, 2026
Precision-guided therapy in H3K27-altered diffuse midline gliomaCampbell J L McKay, Chelsea Mayoh, Phoebe Power, et al.
The Journal of Clinical Investigation|February 6, 2024
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine gliomaRyan J Duchatel, Evangeline R Jackson, Sarah G Parackal, et al.
Pageof 2